Abbott Laboratories (NYSE:ABT)

49.41
Delayed Data
As of Jul 02
 -0.11 / -0.22%
Today’s Change
39.28
Today|||52-Week Range
50.47
+9.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line4.7B6.0B2.6B2.3B
 
 
 
 
 
Depreciation3.0B2.8B1.7B1.5B
 
 
 
 
 
Total Other Cash Flow1.2B2.4B266.0M333.0M
 
 
 
 
 
Funds From Operations9.0B11.2B4.6B4.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-1.1M1.9B1.2B490.0M
 
 
 
 
 
Net Cash Flow - Operating Activities9.0B9.3B3.3B3.7B
 
 
 
 
 
 
InvestingIncrease In Investments-5.1B-12.0B-10.1B-1.5B
 
 
 
 
 
Decrease In Investments5.6B8.9B7.8B5.6B
 
 
 
 
 
Capital Expenditures-1.5B-1.8B-1.1B-1.1B
 
 
 
 
 
Net Assets From Acquisitions -672.5M-1.2B-580.0M-3.3B
 
 
 
 
 
Other Investing - Sources1.9B2.7M21.0M75.0M
 
 
 
 
 
Net Cash Flow Investing260.8M-6.1B-3.9B-202.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-2.0B783.9M2.1B1.3B
 
 
 
 
 
Long Term Borrowings1.0B14.7B9.0M0.00
 
 
 
 
Long Term Debt Reduction-3.0B-11.1B-303.0M-577.0M
 
 
 
 
 
Net Proceeds Stock Sale968.8M1.9B395.0M429.0M
 
 
 
 
 
Common Preferred Redeemed-77.0M-2.4B-1.6B-2.2B
 
 
 
 
 
Common Dividends-2.9B-3.2B-882.0M-1.3B
 
 
 
 
 
Cash Dividends Paid - Total-2.9B-3.2B-882.0M-1.3B
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.006.4B400.0M
 
 
 
Net Cash Flow - Financing-6.0B716.1M-6.7B-2.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-43.0M40.1M-26.0M-143.0M
 
 
 
 
 
 
Net Change In Cash3.2B3.9B-7.3B731.0M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account